Back
Also listed as
MURGY
OTC
Day Range
$603.15
$635.09
52-Week Range
$556.34
$724.64
Volume
99
50D / 200D Avg
$624.04
/
$638.91
Prev Close
$603.03
Price History
Financial Trends
Peer Comparison
vs Financial Services sector median (854 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 13.8 | 10.3 |
| P/B | 2.4 | 1.1 |
| ROE % | 18.3 | 11.7 |
| Net Margin % | 13.4 | 16.8 |
| Rev Growth 5Y % | -7.8 | 11.7 |
| D/E | 0.2 | 0.5 |
Key Takeaways
Revenue declined -7.84% annually over 5 years
Earnings grew 23.43% over the past year
ROE of 18.25% — decent returns on equity
Debt/Equity of 0.19 — conservative balance sheet
Generating 2.83B in free cash flow
P/E of 13.77 — trading at a low valuation
Growth
Revenue Growth (5Y)
-7.84%
Revenue (1Y)6.61%
Earnings (1Y)23.43%
FCF Growth (3Y)N/A
Quality
Return on Equity
18.25%
ROIC16.76%
Net Margin13.44%
Op. Margin20.58%
Safety
Debt / Equity
0.19
Current RatioN/A
Interest Coverage26.62
Valuation
P/E Ratio
13.77
P/B Ratio2.40
EV/EBITDA9.01
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.61% | Revenue Growth (3Y) | 3.22% |
| Earnings Growth (1Y) | 23.43% | Earnings Growth (3Y) | 3.44% |
| Revenue Growth (5Y) | -7.84% | Earnings Growth (5Y) | 47.20% |
| Profitability | |||
| Revenue (TTM) | 42.31B | Net Income (TTM) | 5.69B |
| ROE | 18.25% | ROA | 1.98% |
| Gross Margin | 103.26% | Operating Margin | 20.58% |
| Net Margin | 13.44% | Free Cash Flow (TTM) | 2.83B |
| ROIC | 16.76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.19 | Current Ratio | N/A |
| Interest Coverage | 26.62 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 13.77 | P/B Ratio | 2.40 |
| P/S Ratio | 1.85 | PEG Ratio | 0.43 |
| EV/EBITDA | 9.01 | Dividend Yield | 0.03% |
| Market Cap | 78.28B | Enterprise Value | 78.48B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 42.31B | 39.68B | 39.71B | 64.46B | 58.64B |
| Net Income | 5.69B | 4.61B | 5.31B | 2.93B | 1.21B |
| EPS (Diluted) | 42.78 | 33.87 | 38.12 | 20.94 | 8.63 |
| Gross Profit | 43.69B | 41.06B | 40.76B | 53.79B | 48.67B |
| Operating Income | 8.71B | 7.11B | 10.01B | 4.14B | 1.48B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 286.52B | 273.79B | 298.57B | 312.41B | 297.95B |
| Total Liabilities | 253.77B | 244.02B | 277.37B | 281.46B | 267.95B |
| Shareholders' Equity | 32.64B | 29.65B | 27.09B | 30.83B | 29.89B |
| Total Debt | 6.32B | 4.71B | 6.45B | 6.80B | 6.74B |
| Cash & Equivalents | 6.12B | 8.57B | 9.32B | 8.78B | 9.06B |
| Current Assets | 5.91B | 47.31B | 149.71B | 171.24B | 164.45B |
| Current Liabilities | 0.0 | 84.24B | 15.53B | 15.83B | 14.79B |